Swiss scientists have developed a vaccine for cats that can protect animal lovers who are allergic to them.
Switzerland-based HypoPet AG said its newly developed vaccine called HypoCat works by "immunizing cats against their own major allergen, Fel d 1," an allergen found in catfish. A report from the Journal of Allergy and Clinical Immunology states that ten percent of people are allergic to this particular dandruff.
Gary Jennings, CEO of HypoPet AG, said the vaccine produces a high proportion of antibodies in the cat "These antibodies can bind and neutralize the Fel d 1 allergen produced by the animals."
"The vaccine would help people with cat allergies to avoid typical reactions like rashes, stuffy nose and irritated eyes while reducing the risk of worsening asthma or chronic respiratory disease," the New York Post (1
In a press release, HypoPet wrote that allergies in human cats is one of the The main reasons are why people bring their cats to a shelter or give them up altogether.
The press release said:
Neverth Allergy to owners, friends and relatives is a major cause of cat abandonment. Unfortunately, of the 3.4 million cats that are exposed annually in US cat homes, about 1.4 million of these animals are euthanized. An allergy is also a major reason for leaving cats in urban and domestic environments.
HypoPet added that by reducing the "pet's allergenicity", cat lovers would avoid the difficulty of being forced to give up their pet altogether.  "To achieve this goal, HypoPet uses its innovative vaccine technology with virus-like particles to safely reduce the allergenicity of pets," states the statement or serious side effects in the tested cats. This is due to the fact that cats naturally have a low content of Fel d 1 and the protein does not exert an important function within the animals themselves. If everything goes according to plan, Jennings hopes HypoPet will be able to apply the vaccine to the market by 2022.